CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

OXB Selected as GMP Manufacturing Partner to Support Manufacturing of Plowshare Therapies’ AAV Gene Therapy Programme

PartnershipAAV Gene Therapy ProgrammePositive
AI Analysis

Summary

OXB has signed an agreement with Plowshare Therapies to provide process development and GMP manufacturing services for AAV gene therapies targeting rare genetic diseases, with potential for expansion to additional programs and later-stage manufacturing.

Importance:5/10
Sentiment:
0.60
CDMOGene TherapyAAVManufacturingPartnershipRare Genetic Diseases
Related Companies

Read the original article

Published by GlobeNewswire Pharma on July 16, 2026 11:00 AM

Read Original